Literature DB >> 9566394

Effects of aerobic training in patients with mitochondrial myopathies.

T Taivassalo1, N De Stefano, Z Argov, P M Matthews, J Chen, A Genge, G Karpati, D L Arnold.   

Abstract

We studied the physiologic adaptation of patients with mitochondrial myopathies to aerobic training. Ten patients underwent individually supervised, moderate-intensity aerobic training on a treadmill for 8 weeks. Biochemical and functional measures improved with training. Estimated aerobic capacity increased by 30%. Blood lactate concentrations at rest and after exercise decreased by 30%. Muscle phosphorus magnetic resonance spectroscopy measurements of adenosine diphosphate recovery after exercise improved by more than 60%. Fatigue and tolerance to daily activities also improved. Although the improvement in exercise tolerance may be due in part to reversal of the effects of secondary deconditioning, this uncontrolled clinical trial suggests that aerobic training can benefit patients with mitochondrial myopathies.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9566394     DOI: 10.1212/wnl.50.4.1055

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  21 in total

Review 1.  Biochemical and physiological MR imaging of skeletal muscle at 7 tesla and above.

Authors:  Gregory Chang; Ligong Wang; Arturo Cárdenas-Blanco; Mark E Schweitzer; Michael P Recht; Ravinder R Regatte
Journal:  Semin Musculoskelet Radiol       Date:  2010-05-18       Impact factor: 1.777

Review 2.  Advances in primary mitochondrial myopathies.

Authors:  Isabella Peixoto de Barcelos; Valentina Emmanuele; Michio Hirano
Journal:  Curr Opin Neurol       Date:  2019-10       Impact factor: 5.710

Review 3.  Strength training and aerobic exercise training for muscle disease.

Authors:  Nicoline Bm Voet; Elly L van der Kooi; Baziel Gm van Engelen; Alexander Ch Geurts
Journal:  Cochrane Database Syst Rev       Date:  2019-12-06

4.  Mitochondrial Disease.

Authors:  Roser Pons; Darryl C. De Vivo
Journal:  Curr Treat Options Neurol       Date:  2001-05       Impact factor: 3.598

5.  Mitochondrial dysfunctions in myalgic encephalomyelitis/chronic fatigue syndrome explained by activated immuno-inflammatory, oxidative and nitrosative stress pathways.

Authors:  Gerwyn Morris; Michael Maes
Journal:  Metab Brain Dis       Date:  2013-09-10       Impact factor: 3.584

6.  Endurance exercise is protective for mice with mitochondrial myopathy.

Authors:  Tina Wenz; Francisca Diaz; Dayami Hernandez; Carlos T Moraes
Journal:  J Appl Physiol (1985)       Date:  2009-03-12

Review 7.  Treatment for mitochondrial disorders.

Authors:  Gerald Pfeffer; Kari Majamaa; Douglass M Turnbull; David Thorburn; Patrick F Chinnery
Journal:  Cochrane Database Syst Rev       Date:  2012-04-18

Review 8.  Current and Emerging Clinical Treatment in Mitochondrial Disease.

Authors:  Rory J Tinker; Albert Z Lim; Renae J Stefanetti; Robert McFarland
Journal:  Mol Diagn Ther       Date:  2021-03-01       Impact factor: 4.074

Review 9.  Diagnosis and treatment of mitochondrial myopathies.

Authors:  Gerald Pfeffer; Patrick F Chinnery
Journal:  Ann Med       Date:  2011-08-25       Impact factor: 4.709

Review 10.  Diagnosis and management of mitochondrial disease: a consensus statement from the Mitochondrial Medicine Society.

Authors:  Sumit Parikh; Amy Goldstein; Mary Kay Koenig; Fernando Scaglia; Gregory M Enns; Russell Saneto; Irina Anselm; Bruce H Cohen; Marni J Falk; Carol Greene; Andrea L Gropman; Richard Haas; Michio Hirano; Phil Morgan; Katherine Sims; Mark Tarnopolsky; Johan L K Van Hove; Lynne Wolfe; Salvatore DiMauro
Journal:  Genet Med       Date:  2014-12-11       Impact factor: 8.822

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.